These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19684858)

  • 1. pH Modulation of efflux pump activity of multi-drug resistant Escherichia coli: protection during its passage and eventual colonization of the colon.
    Martins A; Spengler G; Rodrigues L; Viveiros M; Ramos J; Martins M; Couto I; Fanning S; Pagès JM; Bolla JM; Molnar J; Amaral L
    PLoS One; 2009 Aug; 4(8):e6656. PubMed ID: 19684858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of Real-Time Assays To Distinguish Multidrug Efflux Pump-Inhibiting and Outer Membrane-Destabilizing Activities in Escherichia coli.
    Misra R; Morrison KD; Cho HJ; Khuu T
    J Bacteriol; 2015 Aug; 197(15):2479-88. PubMed ID: 25962916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of calcium in the efflux system of Escherichia coli.
    Martins A; Machado L; Costa S; Cerca P; Spengler G; Viveiros M; Amaral L
    Int J Antimicrob Agents; 2011 May; 37(5):410-4. PubMed ID: 21419607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome.
    Guglierame P; Pasca MR; De Rossi E; Buroni S; Arrigo P; Manina G; Riccardi G
    BMC Microbiol; 2006 Jul; 6():66. PubMed ID: 16857052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF).
    Bohnert JA; Schuster S; Fähnrich E; Trittler R; Kern WV
    J Antimicrob Chemother; 2007 Jun; 59(6):1216-22. PubMed ID: 17062614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competition between substrates of the efflux pump system of Salmonella enteritidis.
    Cerca P; Martins A; Couto I; Viveiros M; Amaral L
    In Vivo; 2011; 25(4):597-602. PubMed ID: 21709002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of intrinsic efflux activity of Enterococcus faecalis ATCC29212 by a semi-automated ethidium bromide method.
    Spengler G; Martins A; Schelz Z; Rodrigues L; Aagaard L; Martins M; Costa SS; Couto I; Viveiros M; Fanning S; Kristiansen JE; Molnar J; Amaral L
    In Vivo; 2009; 23(1):81-7. PubMed ID: 19368129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli.
    Kern WV; Steinke P; Schumacher A; Schuster S; von Baum H; Bohnert JA
    J Antimicrob Chemother; 2006 Feb; 57(2):339-43. PubMed ID: 16354747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode of action of the 2-phenylquinoline efflux inhibitor PQQ4R against
    Machado D; Fernandes L; Costa SS; Cannalire R; Manfroni G; Tabarrini O; Couto I; Sabatini S; Viveiros M
    PeerJ; 2017; 5():e3168. PubMed ID: 28516003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Putative Efflux Transporter of the ABC Family, YbhFSR, in
    Feng Z; Liu D; Wang L; Wang Y; Zang Z; Liu Z; Song B; Gu L; Fan Z; Yang S; Chen J; Cui Y
    Front Microbiol; 2020; 11():556. PubMed ID: 32390957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of Vibrio vulnificus RND efflux pumps homologous to Vibrio cholerae VexAB and VexCD, and to Escherichia coli AcrAB.
    Lee S; Yeom JH; Seo S; Lee M; Kim S; Bae J; Lee K; Hwang J
    J Microbiol; 2015 Apr; 53(4):256-61. PubMed ID: 25740377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of intrinsic efflux activity of Escherichia coli K-12 AG100 by an automated ethidium bromide method.
    Viveiros M; Martins A; Paixão L; Rodrigues L; Martins M; Couto I; Fähnrich E; Kern WV; Amaral L
    Int J Antimicrob Agents; 2008 May; 31(5):458-62. PubMed ID: 18343640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of the activity of P-glycoprotein by a semi-automated fluorometric method.
    Spengler G; Viveiros M; Martins M; Rodrigues L; Martins A; Molnar J; Couto I; Amaral L
    Anticancer Res; 2009 Jun; 29(6):2173-7. PubMed ID: 19528478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological characterisation of the efflux pump system of antibiotic-susceptible and multidrug-resistant Enterobacter aerogenes.
    Martins A; Spengler G; Martins M; Rodrigues L; Viveiros M; Davin-Regli A; Chevalier J; Couto I; Pagès JM; Amaral L
    Int J Antimicrob Agents; 2010 Oct; 36(4):313-8. PubMed ID: 20688487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The importance of efflux systems in antibiotic resistance and efflux pump inhibitors in the management of resistance].
    Aygül A
    Mikrobiyol Bul; 2015 Apr; 49(2):278-91. PubMed ID: 26167829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental Evolution of Escherichia coli K-12 in the Presence of Proton Motive Force (PMF) Uncoupler Carbonyl Cyanide
    Griffith JM; Basting PJ; Bischof KM; Wrona EP; Kunka KS; Tancredi AC; Moore JP; Hyman MRL; Slonczewski JL
    Appl Environ Microbiol; 2019 Mar; 85(5):. PubMed ID: 30578262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Efflux Pumps and Environmental pH in Bacterial Multidrug Resistance.
    Nové M; Kincses A; Molnár J; Amaral L; Spengler G
    In Vivo; 2020; 34(1):65-71. PubMed ID: 31882464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of efflux activity of bacteria by a semi-automated fluorometric system.
    Viveiros M; Rodrigues L; Martins M; Couto I; Spengler G; Martins A; Amaral L
    Methods Mol Biol; 2010; 642():159-72. PubMed ID: 20401593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of quorum sensing and efflux pump system by trifluoromethyl ketone proton pump inhibitors.
    Varga ZG; Armada A; Cerca P; Amaral L; Mior Ahmad Subki MA; Savka MA; Szegedi E; Kawase M; Motohashi N; Molnár J
    In Vivo; 2012; 26(2):277-85. PubMed ID: 22351670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of efflux transporter genes on susceptibility of Escherichia coli to tigecycline (GAR-936).
    Hirata T; Saito A; Nishino K; Tamura N; Yamaguchi A
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2179-84. PubMed ID: 15155219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.